AVEO Pharmaceuticals, Inc. (AVEO)

[harry crumb]

upon another review of aveo's catalysts, which there are several that may sweep in in concurrent fashion, the upside is huge. wouldnt surprise us if the pps is in upwards of $12 after EU approval an phase 3 trial news, then theres the FDA here in the states. also, milestone payments, an of course a phase 1 an 2 study going on with other pipeline candidates. oh, then the buyout rumors. hhhhmmmm, i saw a post earlier with JAZZ mentioned, we got in that at 3.50 an still have shares of it to this date. always the possibility aveo is headed that way.